
New study questions the safety of caspase inhibitors for the treatment of liver disease
Many acute and chronic liver diseases, including alcoholic hepatitis, result from apoptotic (programmed) cell death mediated by the enzyme caspase. Caspase inhibitors have therapeutic potential to treat and prevent apoptosis-mediated ...
Sep 9, 2016
0
0